Co-localization of stanniocalcin-1 ligand and receptor in human breast carcinomas

Molecular and Cellular Endocrinology

Volumn 213, Issue 2, 2004, Pages 167-172

  McCudden, Christopher R ^a   Majewski, Agata ^a   Chakrabarti, Subrata ^a   Wagner, Graham F ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Breast cancer; Ligand; Receptor; Stanniocalcin 1

Indexed keywords

HORMONE RECEPTOR; HYPOCALCIN; LIGAND; PEPTIDE HORMONE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER INVASION; CARCINOMA IN SITU; HUMAN; HUMAN TISSUE; MAMMARY GLAND; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TUMOR BIOPSY; TUMOR CELL;

EID: 1142309809     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2003.10.042     Document Type: Article

References (24)

1. Birner P., Oberhuber G., Stani J., Reithofer C., Samonigg H., Hausmaninger H., Kubista E., Kwasny W., Kandioler-Eckersberger D., Gnant M., Jakesz R. Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. Clin. Cancer Res. 7:2001;1669-1675.
2. Bouras T., Southey M.C., Chang A.C., Reddel R.R., Willhite D., Glynne R., Henderson M.A., Armes J.E., Venter D.J. Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res. 62:2002;1289-1295.
3. Charpentier A.H., Bednarek A.K., Daniel R.L., Hawkins K.A., Laflin K.J., Gaddis S., MacLeod M.C., Aldaz C.M. Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res. 60:2000;5977-5983.
4. Dang C.V., Semenza G.L. Oncogenic alterations of metabolism. Trends Biochem. Sci. 24:1999;68-72.
5. Deol H., Stasko S.E., De Niu P., James K.A., Wagner G.F. Post-natal ontogeny of stanniocalcin gene expression in rodent kidney and regulation by dietary calcium and phosphate. Kidney Int. 60:2001;2142-2152.
6. Filvaroff E.H., Guillet S., Zlot C., Bao M., Ingle G., Steinmetz H., Hoeffel J., Bunting S., Ross J., Carano R.A., Powell-Braxton L., Wagner G.F., Eckert R., Gerritsen M.E., French D.M. Stanniocalcin 1 alters muscle and bone structure and function in transgenic mice. Endocrinology. 143:2002;3681-3690.
7. Fujiwara Y., Sugita Y., Nakamori S., Miyamoto A., Shiozaki K., Nagano H., Sakon M., Monden M. Assessment of Stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers. Int. J. Oncol. 16:2000;799-804.
8. Garber M.E., Troyanskaya O.G., Schluens K., Petersen S., Thaesler Z., Pacyna-Gengelbach M., van de Rijn M., Rosen G.D., Perou C.M., Whyte R.I., Altman R.B., Brown P.O., Botstein D., Petersen I. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. U.S.A. 98:2001;13784-13789.
9. Gerritsen M.E., Soriano R., Yang S., Ingle G., Zlot C., Toy K., Winer J., Draksharapu A., Peale F., Wu T.D., Williams P.M. In silico data filtering to identify new angiogenesis targets from a large in vitro gene profiling data set. Physiol. Genomics. 12:2002;13-20.
10. Gruvberger S., Ringner M., Chen Y., Panavally S., Saal L.H., Borg A., Ferno M., Peterson C., Meltzer P.S. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 61:2001;5979-5984.
11. Ismail R.S., Baldwin R.L., Fang J., Browning D., Karlan B.Y., Gasson J.C., Chang D.D. Differential gene expression between normal and tumor-derived ovarian epithelial cells. Cancer Res. 60:2000;6744-6749.
12. Lal A., Peters H., St Croix B., Haroon Z.A., Dewhirst M.W., Strausberg R.L., Kaanders J.H., van der Kogel A.J., Riggins G.J. Transcriptional response to hypoxia in human tumors. J. Natl. Cancer Inst. 93:2001;1337-1343.
13. Liang P., Averboukh L., Keyomarsi K., Sager R., Pardee A.B. Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res. 52:1992;6966-6968.
14. McCudden C.R., James K.A., Hasilo C., Wagner G.F. Characterization of mammalian stanniocalcin receptors: mitochondrial targeting of ligand and receptor for regulation of cellular metabolism. J. Biol. Chem. 277:2002;45249-45258.
15. Osborne C.K. Steroid hormone receptors in breast cancer management. Breast Cancer Res. Treat. 51:1998;227-238.
16. Osborne C.K., Yochmowitz M.G., Knight W.A. III, McGuire W.L. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer. 46:1980;2884-2888.
17. Sheikh-Hamad D., Rouse D., Yang Y. Regulation of stanniocalcin in MDCK cells by hypertonicity and extracellular calcium. Am. J. Physiol. 278:2000;F417-F424.
18. Stasko S.E., Wagner G.F. Possible roles for stanniocalcin during early skeletal patterning and joint formation in the mouse. J. Endocrinol. 171:2001;237-248.
19. Varghese R., Gagliardi A.D., Bialek P.E., Yee S.P., Wagner G.F., Dimattia G.E. Overexpression of human stanniocalcin affects growth and reproduction in transgenic mice. Endocrinology. 143:2002;868-876.
20. Wascher R.A., Huynh K.T., Giuliano A.E., Hansen N.M., Singer F.R., Elashoff D., Hoon D.S.B. Stanniocalcin-1: a novel molecular blood and bone marrow marker for human breast cancer. Clin Cancer Res. 9:2003;1427-1435.
21. Watanabe T., Ichihara M., Hashimoto M., Shimono K., Shimoyama Y., Nagasaka T., Murakumo Y., Murakami H., Sugiura H., Iwata H., Ishiguro N., Takahashi M. Characterization of gene expression induced by RET with MEN2A or MEN2B mutation. Am. J. Pathol. 161:2002;249-256.
22. Welcsh P.L., Lee M.K., Gonzalez-Hernandez R.M., Black D.J., Mahadevappa M., Swisher E.M., Warrington J.A., King M.C. BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 99:2002;7560-7565.
23. Wilson K.S., Roberts H., Leek R., Harris A.L., Geradts J. Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues. Am. J. Pathol. 161:2002;1171-1185.
24. Zhang K.Z., Lindsberg P.J., Tatlisumak T., Kaste M., Olsen H.S., Andersson L.C. Stanniocalcin: A molecular guard of neurons during cerebral ischemia. PNAS. 97:2000;3637-3642.